https://bi1383298inhibitor.com..../evaluation-of-envir
The development of novel and promising drug candidates for COVID-19 has shown considerable progress over the last three years. Yet, the emergence of SARS-CoV-2 mutations that cause new strains resistant to currently used clinic drugs calls for the development of novel potent and broadly effective therapeutic agents, focusing on multiple weak points in the viral proteins. This study leveraged two deep learning generative models and molecular
Gefällt mir
Kommentar
Teilen
